Ultragenyx: Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
⚠️ This profile was automatically generated by the AYA bot. Information may be inaccurate. Claim this profile to correct and certify your data.
Identification
* This score measures how readable the company is by AIs (ChatGPT, Gemini, Claude...). The higher the score, the more visible and recommendable the company is.
Public Key (AYA ID)
ce1c8268-78ba-5ba1-8c2d-fb4de6b3a022
Issue date
2 juin 2026
Validity
—
Last modified: 2 juin 2026
Semantic Data (AI)
"Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward."
Indexed Keywords
Supported Protocols
- ✓ JSON-LD Structure
- ✓ ASR v3.0 Standard
Related entities
Other entities in the same sector or country
Secured by AYO Consensus • Swiss Hosting